These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3283804)

  • 1. Comparison of adinazolam, amitriptyline, and placebo in the treatment of melancholic depression.
    Hicks F; Robins E; Murphy GE
    Psychiatry Res; 1988 Feb; 23(2):221-7. PubMed ID: 3283804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of adinazolam, amitriptyline, and diazepam in endogenous depressive inpatients exhibiting DST nonsuppression or abnormal contingent negative variation.
    Ansseau M; Devoitille JM; Papart P; Vanbrabant E; Mantanus H; Timsit-Berthier M
    J Clin Psychopharmacol; 1991 Jun; 11(3):160-5. PubMed ID: 2066454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder.
    Amsterdam JD; Kaplan M; Potter L; Bloom L; Rickels K
    Psychopharmacology (Berl); 1986; 88(4):484-8. PubMed ID: 3085137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adinazolam mesylate and placebo in depressed outpatients: a 6-week, double-blind comparison.
    Cohn JB; Pyke RE; Wilcox CS
    J Clin Psychiatry; 1988 Apr; 49(4):142-7. PubMed ID: 3281930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind efficacy and safety study comparing adinazolam mesylate and placebo in depressed inpatients.
    Smith WT; Glaudin V
    Acta Psychiatr Scand; 1986 Sep; 74(3):238-45. PubMed ID: 3538786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adinazolam--a new antidepressant: findings of a placebo-controlled, double-blind study in outpatients with major depression.
    Dunner D; Myers J; Khan A; Avery D; Ishiki D; Pyke R
    J Clin Psychopharmacol; 1987 Jun; 7(3):170-2. PubMed ID: 3298327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of adinazolam and desipramine in the treatment of major depression.
    Kennedy SH; de Groot J; Ralevski E; Reed K
    Int Clin Psychopharmacol; 1991; 6(2):65-76. PubMed ID: 1960382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fixed-dose study of adinazolam-SR tablets in generalized anxiety disorder.
    Wilcox CS; Ryan PJ; Morrissey JL; Cohn JB; DeFrancisco DF; Linden RD; Heiser JF
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Oct; 18(6):979-93. PubMed ID: 7824763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet alpha-2 adrenoreceptor activity pre-treatment and post-treatment in major depressive disorder with melancholia.
    Bhatia SC; Hsieh HH; Theesen KA; Townley RG; Andersen JM; Weiss S; Agrawal DK
    Res Commun Chem Pathol Pharmacol; 1991 Oct; 74(1):47-57. PubMed ID: 1666199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodiazepines as antidepressants. A triazolobenzodiazepine used to treat depression.
    Feighner JP
    Mod Probl Pharmacopsychiatry; 1982; 18():196-212. PubMed ID: 6124883
    [No Abstract]   [Full Text] [Related]  

  • 11. Adinazolam, diazepam, imipramine, and placebo in major depressive disorder: a controlled study.
    Rickels K; London J; Fox I; Hassman H; Csanalosi I; Weise C
    Pharmacopsychiatry; 1991 Jul; 24(4):127-31. PubMed ID: 1754608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression.
    Rickels K; Feighner JP; Smith WT
    Arch Gen Psychiatry; 1985 Feb; 42(2):134-41. PubMed ID: 2858187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled comparison of two doses of milnacipran (F 2207) and amitriptyline in major depressive inpatients.
    Ansseau M; von Frenckell R; Mertens C; de Wilde J; Botte L; Devoitille JM; Evrard JL; De Nayer A; Darimont P; Dejaiffe G
    Psychopharmacology (Berl); 1989; 98(2):163-8. PubMed ID: 2569214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparative trial of zimelidine, amitriptyline, and placebo in patients with mixed anxiety and depression.
    Amsterdam JD; Case WG; Csanalosi E; Singer M; Rickels K
    Pharmacopsychiatry; 1986 May; 19(3):115-9. PubMed ID: 2941771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuation therapy with lithium and amitriptyline in unipolar depressive illness: a randomized, double-blind, controlled trial.
    Glen AI; Johnson AL; Shepherd M
    Psychol Med; 1984 Feb; 14(1):37-50. PubMed ID: 6143340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial.
    Paykel ES; Hollyman JA; Freeling P; Sedgwick P
    J Affect Disord; 1988; 14(1):83-95. PubMed ID: 2963054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.
    Carter CS; Fawcett J; Hertzman M; Papp LA; Jones W; Patterson WM; Swinson RP; Weise CC; Maddock RJ; Denahan AQ
    J Clin Psychiatry; 1995 May; 56(5):202-10. PubMed ID: 7737960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of controlled studies of adinazolam mesylate in patients with major depressive disorder.
    Feighner JP
    Psychopharmacol Bull; 1986; 22(1):186-91. PubMed ID: 3523576
    [No Abstract]   [Full Text] [Related]  

  • 20. Mianserin versus amitriptyline for depression: a double-blind 6-week trial.
    Rabkin JG; McGrath PJ; Quitkin FM; Fyer A; Stewart JW; Liebowitz MR; Markowitz J
    Neuropsychobiology; 1984; 12(4):224-8. PubMed ID: 6398862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.